October 2, 2019

Successful Mission for Ruggedized Bioprinter

The Geneva Foundation and the Uniformed Services University (USU) 4D Bio3 Program, in support of the U.S. Military, recently completed a pilot project involving the biofabrication of medical products in an austere military environment, with the goal of advancing future next-gen treatments for the Nation’s deployed warfighters. Advances in 3D printing and biofabrication have the potential to provide unprecedented benefits for the warfighter, including the direct repair or replacement of damaged tissues.

This successful pilot project, led onsite by LTC Jason Barnhill at the United States Military Academy West Point, Department of Chemistry and Life Science, represents a multi-disciplinary collaboration which included nScrypt and RoosterBio,Inc. nScrypt’s  bioprinter, called the Austere BioAssembly Tool (ABAT™), a lightweight, ruggedized bioprinter that was custom designed by nScrypt based on their 3D printer experiences with the BioFabrication Facility on the International Space Station. The ABAT™ provides 3D printing solutions with a wide range of materials, including polymers, electronic components, and biologics. Along with the printer, basic supplies and raw materials were transported to the austere environment, including RoosterBio’s Ready To Print (RTP) human mesenchymal stem/stromal cells (hMSCs); a first-of-its-kind product that was designed to radically simplify and standardize the most complex and labor intensive aspects of bioprinting. This technology enables austere printing in a resource-limited setting as they are the only cells that allow for same-day bioprinting capabilities.

Read the full press release here to learn more about the project’s biofabrication achievements such as a 3D bioprinted meniscus and bioactive bandages.

*Photo L to R: Joel Gaston (4D Bio3, Geneva), John Getz (RoosterBio, Inc), LTC Jason Barnhill (United States Military Academy), Vincent B. Ho, (4D Bio3 Director, USU), Ken Church (nScrypt), Kelli Blaize-Wise (4D Bio3, Geneva), Linzie Wagner (4D Bio3, Geneva)